180 related articles for article (PubMed ID: 36040709)
1. Effect of early metoprolol before PCI in ST-segment elevation myocardial infarction on infarct size and left ventricular ejection fraction. A systematic review and meta-analysis of clinical trials.
Motawea KR; Gaber H; Singh RB; Swed S; Elshenawy S; Talat NE; Elgabrty N; Shoib S; Wahsh EA; Chébl P; Reyad SM; Rozan SS; Aiash H
Clin Cardiol; 2022 Oct; 45(10):1011-1028. PubMed ID: 36040709
[TBL] [Abstract][Full Text] [Related]
2. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
[TBL] [Abstract][Full Text] [Related]
3. Effect of Early Metoprolol During ST-Segment Elevation Myocardial Infarction on Left Ventricular Strain: Feature-Tracking Cardiovascular Magnetic Resonance Substudy From the METOCARD-CNIC Trial.
Podlesnikar T; Pizarro G; Fernández-Jiménez R; Montero-Cabezas JM; Sánchez-González J; Bucciarelli-Ducci C; Ajmone Marsan N; Fras Z; Bax JJ; Fuster V; Ibáñez B; Delgado V
JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1188-1198. PubMed ID: 30219400
[TBL] [Abstract][Full Text] [Related]
4. Early Intravenous Beta-Blockers in Patients With ST-Segment Elevation Myocardial Infarction Before Primary Percutaneous Coronary Intervention.
Roolvink V; Ibáñez B; Ottervanger JP; Pizarro G; van Royen N; Mateos A; Dambrink JE; Escalera N; Lipsic E; Albarran A; Fernández-Ortiz A; Fernández-Avilés F; Goicolea J; Botas J; Remkes W; Hernandez-Jaras V; Kedhi E; Zamorano JL; Navarro F; Alfonso F; García-Lledó A; Alonso J; van Leeuwen M; Nijveldt R; Postma S; Kolkman E; Gosselink M; de Smet B; Rasoul S; Piek JJ; Fuster V; van 't Hof AWJ;
J Am Coll Cardiol; 2016 Jun; 67(23):2705-2715. PubMed ID: 27050189
[TBL] [Abstract][Full Text] [Related]
5. Remote ischemic conditioning during primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction: a systematic review and meta-analysis.
Gong R; Wu YQ
J Cardiothorac Surg; 2019 Jan; 14(1):14. PubMed ID: 30696461
[TBL] [Abstract][Full Text] [Related]
6. Impact of the Timing of Metoprolol Administration During STEMI on Infarct Size and Ventricular Function.
García-Ruiz JM; Fernández-Jiménez R; García-Alvarez A; Pizarro G; Galán-Arriola C; Fernández-Friera L; Mateos A; Nuno-Ayala M; Aguero J; Sánchez-González J; García-Prieto J; López-Melgar B; Martínez-Tenorio P; López-Martín GJ; Macías A; Pérez-Asenjo B; Cabrera JA; Fernández-Ortiz A; Fuster V; Ibáñez B
J Am Coll Cardiol; 2016 May; 67(18):2093-2104. PubMed ID: 27052688
[TBL] [Abstract][Full Text] [Related]
7. Long-term benefit of early pre-reperfusion metoprolol administration in patients with acute myocardial infarction: results from the METOCARD-CNIC trial (Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction).
Pizarro G; Fernández-Friera L; Fuster V; Fernández-Jiménez R; García-Ruiz JM; García-Álvarez A; Mateos A; Barreiro MV; Escalera N; Rodriguez MD; de Miguel A; García-Lunar I; Parra-Fuertes JJ; Sánchez-González J; Pardillos L; Nieto B; Jiménez A; Abejón R; Bastante T; Martínez de Vega V; Cabrera JA; López-Melgar B; Guzman G; García-Prieto J; Mirelis JG; Zamorano JL; Albarrán A; Goicolea J; Escaned J; Pocock S; Iñiguez A; Fernández-Ortiz A; Sánchez-Brunete V; Macaya C; Ibanez B
J Am Coll Cardiol; 2014 Jun; 63(22):2356-62. PubMed ID: 24694530
[TBL] [Abstract][Full Text] [Related]
8. Ischemic Postconditioning Confers No Benefit to Left Ventricular Systolic Function: A Meta-Analysis of Cardiac Magnetic Resonance Imaging Results.
Bergman I; Boyle D; Braver O; Gelikas S; Wexler Y; Omelchenko A; Assali A; Nussinovitch U
Am J Cardiol; 2023 Dec; 208():126-133. PubMed ID: 37837795
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment-Elevation Myocardial Infarction: EARLY-MYO Trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction).
Pu J; Ding S; Ge H; Han Y; Guo J; Lin R; Su X; Zhang H; Chen L; He B;
Circulation; 2017 Oct; 136(16):1462-1473. PubMed ID: 28844990
[TBL] [Abstract][Full Text] [Related]
10. Short-term efficacy of angiotensin receptor-neprilysin inhibitor treatment in patients with ST-segment elevation myocardial infarction with reduced ejection fraction after primary percutaneous coronary intervention: a propensity score matching study.
Zhang Q; Qiao B; Han Y; Sun S; Wang B; Wei S
BMC Cardiovasc Disord; 2022 Nov; 22(1):463. PubMed ID: 36333668
[TBL] [Abstract][Full Text] [Related]
11. Early intravenous beta-blockers in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: A patient-pooled meta-analysis of randomized clinical trials.
Hoedemaker NP; Roolvink V; de Winter RJ; van Royen N; Fuster V; García-Ruiz JM; Er F; Gassanov N; Hanada K; Okumura K; Ibáñez B; van 't Hof AW; Damman P
Eur Heart J Acute Cardiovasc Care; 2020 Aug; 9(5):469-477. PubMed ID: 30759994
[TBL] [Abstract][Full Text] [Related]
12. Complete Revascularization Versus Culprit Lesion Only in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: A DANAMI-3-PRIMULTI Cardiac Magnetic Resonance Substudy.
Kyhl K; Ahtarovski KA; Nepper-Christensen L; Ekström K; Ghotbi AA; Schoos M; Göransson C; Bertelsen L; Helqvist S; Holmvang L; Jørgensen E; Pedersen F; Saunamäki K; Clemmensen P; De Backer O; Høfsten DE; Køber L; Kelbæk H; Vejlstrup N; Lønborg J; Engstrøm T
JACC Cardiovasc Interv; 2019 Apr; 12(8):721-730. PubMed ID: 31000010
[TBL] [Abstract][Full Text] [Related]
13. Does Oral Beta-Blocker Therapy Improve Long-Term Survival in ST-Segment Elevation Myocardial Infarction With Preserved Systolic Function? A Meta-Analysis.
Misumida N; Harjai K; Kernis S; Kanei Y
J Cardiovasc Pharmacol Ther; 2016 May; 21(3):280-5. PubMed ID: 26424094
[TBL] [Abstract][Full Text] [Related]
14. Five-Year Outcomes and Prognostic Value of Feature-Tracking Cardiovascular Magnetic Resonance in Patients Receiving Early Prereperfusion Metoprolol in Acute Myocardial Infarction.
Podlesnikar T; Pizarro G; Fernández-Jiménez R; Montero-Cabezas JM; Sánchez-González J; Bucciarelli-Ducci C; Ajmone Marsan N; Fras Z; Bax JJ; Fuster V; Ibáñez B; Delgado V
Am J Cardiol; 2020 Oct; 133():39-47. PubMed ID: 32819681
[TBL] [Abstract][Full Text] [Related]
15. Incidence and Risk Factors of Left Ventricular Thrombus in Acute ST-Segment Elevation Myocardial Infarction Treated by Primary Percutaneous Coronary Intervention: A Meta-Analysis.
Wang P; Ye X; Yan D; Peng Y; Zhang Z
Med Princ Pract; 2022; 31(5):415-423. PubMed ID: 35797977
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and Predictors of Contrast-Induced Nephropathy (CIN) in Patients with ST-Segment Elevation Myocardial Infarction (STEMI) Undergoing Percutaneous Coronary Intervention (PCI): A Meta-Analysis.
He H; Chen XR; Chen YQ; Niu TS; Liao YM
J Interv Cardiol; 2019; 2019():2750173. PubMed ID: 31772520
[TBL] [Abstract][Full Text] [Related]
17. Intravenous metoprolol during ongoing STEMI ameliorates markers of ischemic injury: a METOCARD-CNIC trial electrocardiographic study.
Díaz-Munoz R; Valle-Caballero MJ; Sanchez-Gonzalez J; Pizarro G; García-Rubira JC; Escalera N; Fuster V; Fernández-Jiménez R; Ibanez B
Basic Res Cardiol; 2021 Jul; 116(1):45. PubMed ID: 34279726
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of Long-Term Oral Beta-Blocker Therapy in Patients Who Underwent Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction With Preserved Left Ventricular Ejection Fraction: A Systematic Review and Meta-analysis.
Maqsood MH; Alam M; Atar D; Birnbaum Y
J Cardiovasc Pharmacol; 2021 Jan; 77(1):87-93. PubMed ID: 33136764
[TBL] [Abstract][Full Text] [Related]
19. The contemporary value of peak creatine kinase-MB after ST-segment elevation myocardial infarction above other clinical and angiographic characteristics in predicting infarct size, left ventricular ejection fraction, and mortality.
Hartman MHT; Eppinga RN; Vlaar PJJ; Lexis CPH; Lipsic E; Haeck JDE; van Veldhuisen DJ; van der Horst ICC; van der Harst P
Clin Cardiol; 2017 May; 40(5):322-328. PubMed ID: 28026027
[TBL] [Abstract][Full Text] [Related]
20. Clinical Efficacy and Safety of Early Intravenous Administration of Beta-Blockers in Patients Suffering from Acute ST-Segment Elevation Myocardial Infarction Without Heart Failure Undergoing Primary Percutaneous Coronary Intervention: A Study-Level Meta-Analysis of Randomized Clinical Trials.
Sun B; Wang CY; Chen RR
Cardiovasc Drugs Ther; 2023 Apr; ():. PubMed ID: 37002468
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
